Literature DB >> 30937461

The potential for PET-guided revascularization of coronary artery disease.

Matthieu Pelletier-Galarneau1,2, Terrence D Ruddy3.   

Abstract

Entities:  

Year:  2019        PMID： 30937461     DOI： 10.1007/s00259-019-04316-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  34 in total

1.  18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.

Authors:  Arun Abraham; Graham Nichol; Kathryn A Williams; Ann Guo; Robert A deKemp; Linda Garrard; Ross A Davies; Lloyd Duchesne; Haissam Haddad; Benjamin Chow; Jean DaSilva; Rob S B Beanlands
Journal:  J Nucl Med       Date:  2010-03-17       Impact factor: 10.057

2.  Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.

Authors:  R J Kalliokoski; K K Kalliokoski; J Sundell; E Engblom; M Penttinen; I Kantola; O T Raitakari; J Knuuti; P Nuutila
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983

4.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

5.  Bias in iterative reconstruction of low-statistics PET data: benefits of a resolution model.

Authors:  M D Walker; M-C Asselin; P J Julyan; M Feldmann; P S Talbot; T Jones; J C Matthews
Journal:  Phys Med Biol       Date:  2011-01-20       Impact factor: 3.609

6.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

Review 7.  Image-guided cancer therapy using PET/CT.

Authors:  Jeffrey T Yap; Jonathan P J Carney; Nathan C Hall; David W Townsend
Journal:  Cancer J       Date:  2004 Jul-Aug       Impact factor: 3.360

8.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Authors:  Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

9.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

10.  Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease.

Authors:  R Parkash; R A deKemp; T D Ruddy; A Kitsikis; R Hart; L Beauchesne; L Beauschene; Kathryn Williams; R A Davies; M Labinaz; R S B Beanlands
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.